Ab initio structure determination of anhydrous sodium alendronate from laboratory powder X-ray diffraction data

Sodium alendronate, a member of bisphosphonate class of compounds commonly used for treatment of generalized bone disorders, exists in various hydrated forms. Dehydration of sodium alendronate trihydrate has been studied using variable temperature X-ray powder diffraction technique. The crystal stru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 2009-06, Vol.98 (6), p.2113-2121
Hauptverfasser: Asnani, Minakshi, Vyas, K., Bhattacharya, Apurba, Devarakonda, Surya, Chakraborty, Santu, Mukherjee, Alok Kumar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sodium alendronate, a member of bisphosphonate class of compounds commonly used for treatment of generalized bone disorders, exists in various hydrated forms. Dehydration of sodium alendronate trihydrate has been studied using variable temperature X-ray powder diffraction technique. The crystal structure of anhydrous sodium alendronate, prepared by heating the trihydrate sodium alendronate at 150°C, has been determined from X-ray powder data using direct space global optimization technique for structure solution, followed by the Rietveld refinement. The structure of the anhydrous form of sodium alendronate is compared with that of the trihydrate form, which was determined previously from single crystal X-ray diffraction data. Both anhydrous and trihydrate sodium alendronate crystallize in monoclinic system with space group P21/n. The crystal structure of the anhydrous sodium alendronate is built by edge-sharing of NaO6 octahedra into a two-dimensional molecular sheet in the (011) plane, whereas in the trihydrate compound, one-dimensional chain along the (010) direction is generated by corner sharing of NaO6 octahedra. © 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2113–2121, 2009
ISSN:0022-3549
1520-6017
DOI:10.1002/jps.21561